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Atrial ﬁbrillation is the most common arrhythmic compli-
cation observed after cardiac surgery. The reported incidence
of post-operative atrial ﬁbrillation (POAF) after cardiac
surgery ranges from 10% to 65% (1). The wide range of
incidence is driven by myriad factors, including differences
in surgical procedure, patient demographic characteristics,
POAF surveillance method, duration of surveillance, and
criteria for diagnosis. POAF typically occurs 2 to 4 days after
surgery and often resolves spontaneously or with modest
medical treatment. Despite its rather predictable course,
multiple published studies have demonstrated that POAF
has been associated with longer hospital length of stay, longer
rehabilitation length of stay, signiﬁcantly higher overall costs
associated with the procedure, and most importantly, more
frequent and severe patient morbidities (1,2).See page 1510The established mechanisms that contribute to POAF
have been recently summarized in the literature (3). Facil-
itating factors in the mechanism of POAF can be classiﬁed
into acute factors (related to the surgical intervention) and
chronic factors (related to underlying atrial pathology and
age). The delayed onset and transient nature of POAF
suggest that components of the pro-arrhythmic effect of
cardiac surgery take some time to develop and have
reversible mechanisms. Inherently, some of this effect is due
to the disruption of normal cardiac and thoracic physiology,
as evidenced by decreasing rates of POAF from cardiac
surgery (10% to 65%) (1) to noncardiac, thoracic surgery
(9% to 29%) (4) to noncardiac, nonthoracic surgery (1% to
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a paucity of data comparing rates of POAF for similar
procedures that can be performed with and without a
pericardiotomy.
Transcatheter aortic valve replacement (TAVR) is a newly
established treatment option for patients with symptomatic
aortic stenosis who are high risk for open surgery. Because a
similar procedural result is achieved with TAVR and surgical
aortic valve replacement, and because only one procedure
involves a pericardiotomy, this population provides a direct
way to evaluate the relative contribution of pericardial in-
vasion to the development of POAF. Moreover, because
TAVR can be delivered in different ways (transfemoral,
transapical, and transaortic), there are unique risks for each
procedure. Understanding the incidence of POAF for each
procedure could be important for clinicians to appropriately
council patients and consider pre-operative prevention
measures.
In this issue of the Journal, Tanawuttiwat et al. (6) extend
our understanding of POAF into the rapidly developing
world of TAVR. Their study is a single-center, retrospective
analysis of consecutive patients who underwent aortic valve
replacement from March 2010 to September 2012. Major
exclusions included a history of AF, bicuspid aortic valve, and
death within 48 h after surgery. A total of 123 subjects were
included in the analysis, with POAF as the main outcome of
interest. Procedural and hospital telemetry data were used to
characterize the incidence of POAF during the entire hos-
pitalization and at a standard 30-day follow-up clinic visit.
Demographic, clinical, and echocardiographic data were used
to adjust for effects of confounding variables. Patients were
classiﬁed by procedural method of AVR: surgical (SAVR),
transfemoral (TF-TAVR), transapical (TA-TAVR), or
transaortic (TAo-TAVR).
The mean age of this cohort was approximately 85 years,
and the group was almost entirely of Caucasian ethnicity.
The pre-operative mean Society of Thoracic Surgeons
(STS) risk score was 7.67  3.45. No oral antiarrhythmic
agents were used to prevent AF, although surgical patients
received post-operative atrial pacing for at least 24 h and
had other important differences in post-operative care.
Overall, POAF was identiﬁed in 42.3% of this cohort. Not
surprisingly, POAF was associated with lung disease, left
atrial enlargement, left ventricular hypertrophy, and pro-
longed intubation.
The main ﬁnding of the study was that POAF incidence
varied according to procedural type, with the highest inci-
dence in SAVR (60%) and TA-TAVR (53%), and then
TAo-TAVR (33%) followed by TF-TAVR (14%). The
investigators used multivariate regression modeling to
compare surgical versus nonsurgical techniques, procedures
with and without pericardiotomy, and procedures with and
without a chest wall incision. After multivariate analysis, the
development of POAF was most closely associated with
procedures that involved a pericardiotomy (SAVR and TA-
TAVR) versus without pericardiotomy (odds ratio: 0.18;
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152195% conﬁdence interval: 0.05 to 0.59). Compared with
SAVR, only the TF-TAVR procedure had a statistically
supported lower incidence in POAF, although there were
strong trends in the same direction for the other TAVR
procedures as well.
Despite the inherent limitations of a retrospective single-
center study, the investigators are to be commended for
conducting a rigorous collection and evaluation of the data.
Although there were relatively small numbers of patients in
each treatment group, the high rates of observed POAF
allowed for an adequate assessment of the outcome. The
main drawback to this study was the inherent biases of
nonrandomized treatment arms, speciﬁcally patient selection
of SAVR and TAVR. The criteria for choosing patients for
TAVR (deemed inoperable or with an estimated surgical
mortality >15%) clearly chose a less healthy and older group
of patients. Nevertheless, the highest POAF incidence
occurred in the group that was self-selected to be younger
and healthier, which seemed to strengthen the validity of the
investigators’ observations. Among the TAVR choices, the
transfemoral approach was the preferred method, and other
methods were only chosen in cases of small iliofemoral
arterial diameter. This likely introduced bias of patient size
or other vascular disease among the different groups of
TAVR. Other clear differences existed in post-operative
treatment strategies involving atrial pacing, more aggressive
blood transfusions, and presumably, longer duration of
mechanical ventilation in the surgical arm. Remaining
unanswered is the relative contribution of the surgery itself
or the actual post-operative care that led to the higher rates
of POAF in the SAVR group. Clinically, this might not
mean much because the 2 will remain linked (cardiac surgery
requires rigorous post-operative care).
Although POAF is strongly linked to longer hospital
stays and higher cost of care, the more immediate and
tangible concern for patients is thromboembolic complica-
tions, especially cerebrovascular accidents (CVA). In the
current study, the investigators made additional observations
about the timing and duration of the POAF, the variable
anticoagulation strategies, and the incidence of CVA. There
were too few CVA events to draw sustainable conclusions.
However, of the 5 CVAs, 4 occurred in the TF-TAVR
group. Three of these occurred in the early in the post-
operative course, independently of the development of AF,
and presumably were related to manipulation of the delivery
system within the aorta. In this cohort of 123 patients, only
2 CVAs could have been related to POAF. When choosing
the type of TAVR, minimizing the stroke rate seems to bemore related to patient factors and procedural type than to
the presence of POAF. This was supported by published
observations from the PARTNER 1A (Placement of
AoRtic TraNscathetER Valves) trial, in which the risk of
early neurologic events was greater in the TAVR group
(5.5%) than the SAVR group (2.4%; p ¼ 0.04), although
over time, this difference was no longer demonstrated (7).
This risk is likely to diminish with less traumatic delivery
systems, improved technique, and inclusion of lower-risk
patients.
In our increasingly cost-conscious world of medical care,
minimizing risks of complications and safely reducing the
length of a hospitalization are desirable goals. The results
from the study by Tanawuttiwat et al. (6) add to our overall
understanding of the contribution of pericardiotomy to the
incidence of POAF. Decisions about the relative merits of
SAVR versus TAVR and between types of TAVR should
include data from this study. Extended further, the unique
comparisons of procedures with and without pericardiotomy
may provide a way to study speciﬁc mechanisms related to
the pericardium and help develop targeted, cost-effective AF
prevention strategies.
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